Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Baseline characteristics in the Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE)

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. The Glycemic Effect of Liraglutide Evaluated by Continuous Glucose Monitoring in Persons with Type 2 Diabetes Receiving Dialysis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Assessment of the sublingual microcirculation with the GlycoCheck system: Reproducibility and examination conditions

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Gut microbiota profile and selected plasma metabolites in type 1 diabetes without and with stratification by albuminuria

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Cardiovascular and renal outcomes by baseline albuminuria status and renal function - results from the LEADER randomized trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Hans-Henrik Parving
  • Barry M Brenner
  • John J V McMurray
  • Dick de Zeeuw
  • Steven M Haffner
  • Scott D Solomon
  • Nish Chaturvedi
  • Frederik Persson
  • Maria Nicolaides
  • Alexia Richard
  • Zhihua Xiang
  • Juergen Armbrecht
  • Marc A Pfeffer
  • ALTITUDE Investigators
View graph of relations
Patients with type 2 diabetes are at enhanced risk for macro- and microvascular complications. Albuminuria and/or reduced kidney function further enhances the vascular risk. We initiated the Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE). Aliskiren, a novel direct renin inhibitor, which lowers plasma renin activity, may thereby provide greater cardio-renal protection compared with angiotensin converting enzyme inhibitor (ACEi) or angiotensin receptor blocker (ARB) alone.
Original languageEnglish
JournalJournal of the Renin-Angiotensin-Aldosterone System
Volume13
Issue number3
Pages (from-to)387-93
Number of pages7
ISSN1470-3203
DOIs
Publication statusPublished - 2012

ID: 36594289